Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort
Abstract To comprehensively assess whether p75ECD in urine could be a candidate biomarker for ALS evaluation. Urine samples were collected from 101 ALS patients, 108 patients with other neurological disease (OND) and 97 healthy controls. 61 ALS patients were followed up with clinical data including...
Guardado en:
Autores principales: | Rui Jia, Stephanie Shepheard, Jiaoting Jin, Fangfang Hu, Xing Zhao, Li Xue, Li Xiang, Huaguang Qi, Qiumin Qu, Feng Guo, Mary-Louise Rogers, Jingxia Dang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c278ef9e17944d80b928e430c2d24fc2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Extracellular Vesicles as Innovative Treatment Strategy for Amyotrophic Lateral Sclerosis
por: Ke Wang, et al.
Publicado: (2021) -
Amyotrophic lateral sclerosis and frontotemporal degeneration
Publicado: (2000) -
The cortical signature of amyotrophic lateral sclerosis.
por: Federica Agosta, et al.
Publicado: (2012) -
Abnormal RNA stability in amyotrophic lateral sclerosis
por: E. M. Tank, et al.
Publicado: (2018) -
Current and emerging treatments for amyotrophic lateral sclerosis
por: Stefano Zoccolella, et al.
Publicado: (2009)